 - Any additional standard or investigational anticancer agents, such as chemotherapy, immunotherapy, targetedbiologic therapy, endocrine therapy, etc., even if utilized as treatment of non-cancer indications. ODM-201 must be permanently discontinued upon initiation of a non-protocol standard or investigational antineoplastic therapy prior to surgery. 